FdaApplication
ANDA 213395
Identifiers
- fda_app_no: ANDA213395
Properties
| Property | Value |
|---|---|
| applicant_name | NAVINTA LLC |
| application_type | ANDA |
| approval_date | 2022-06-22 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CARGLUMIC ACID | CARGLUMIC ACID | 200MG | TABLET, FOR SUSPENSION;ORAL |
1 product